Champions Oncology (NASDAQ:CSBR) just reported results for the fourth quarter of 2024.
- Champions Oncology reported earnings per share of 1 cent. This was above the analyst estimate for EPS of -16 cents.
- The company reported revenue of $14.00 million.
- This was 10.33% better than the analyst estimate for revenue of $12.69 million.